![What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics. - Abstract - Europe PMC What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5739508/bin/ppat.1006762.g002.jpg)
What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics. - Abstract - Europe PMC
National Coordination Centre for Rare Diseases at Faculty Hospital Motol Národní koordinační centrum ve Fakultní nemocnici
![Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations - ScienceDirect Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199312002354-gr1.jpg)
Distribution of CFTR mutations in the Czech population: Positive impact of integrated clinical and laboratory expertise, detection of novel/de novo alleles and relevance for related/derived populations - ScienceDirect
CONSOLIDATED FINANCIAL STATEMENTS OF THE F.I.L.A. GROUP SEPARATE FINANCIAL STATEMENTS OF F.I.L.A. S.p.A.
![Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study | SpringerLink Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10198-015-0759-9/MediaObjects/10198_2015_759_Fig1_HTML.gif)
Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study | SpringerLink
What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics | PLOS Pathogens
![Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - ScienceDirect Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199321013047-gr2.jpg)
Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - ScienceDirect
![Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - Journal of Cystic Fibrosis Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - Journal of Cystic Fibrosis](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4b98d6a0-32ad-4163-92b9-92cc0dad6d9f/gr1_lrg.jpg)